Bio Sequence

Biological Glossary | What is Mutation?

17 November 2023
2 min read

In biology, a mutation is a permanent alteration to the nucleotide sequence of the genome of an organism, virus, or extrachromosomal DNA. These changes can include substitutions (where one base is replaced by another), insertions or deletions (where bases are added or removed), and more complex rearrangements. Mutations can occur due to a variety of mechanisms, such as: Errors during DNA replication or cell division (mitosis or meiosis)Exposure to environmental factors called mutagens, which include ultraviolet radiation and chemicals that can damage DNAViral infections that can integrate into the DNA of a hostThe action of mobile genetic elements, such as transposons, which can jump around within the genome and cause insertions or deletions.

Depending on where they occur, mutations can be classified as germline or somatic. Germline mutations happen in the reproductive cells (sperm and eggs) and can be passed on to offspring, thereby potentially affecting future generations. Somatic mutations occur in non-reproductive cells and are not heritable.

Mutations can have a range of effects on the phenotype, which is the set of observable characteristics of an organism. Some mutations may be neutral, having no apparent effect, while others can cause significant changes that might be beneficial, harmful, or neutral to the organism. In the process of evolution, these genetic variations provide the raw material upon which natural selection can act, leading to adaptive changes in populations over time. Additionally, mutations are significant in medicine and health as they can lead to diseases like cancer and contribute to the diversity of the immune system, allowing it to recognize and combat various pathogens.

Free registration is available for the Bio biological sequence database: https://bio-patsnap-com.libproxy1.nus.edu.sg. Act now to expedite your sequence search tasks.

图片包含 图示

描述已自动生成

Ventyx Biosciences announces Phase 2 results for VTX958 in psoriasis and provides a company update
Latest Hotspot
3 min read
Ventyx Biosciences announces Phase 2 results for VTX958 in psoriasis and provides a company update
17 November 2023
Ventyx Biosciences reports outcomes of the second phase study of VTX958 in moderate-to-severe plaque psoriasis patients and delivers a company update.
Read →
Osimertinib mesylate: brief review of its R&D progress and the clinical result in 2023 ESMO
ESMO 2023
4 min read
Osimertinib mesylate: brief review of its R&D progress and the clinical result in 2023 ESMO
16 November 2023
The 2023 ESMO Congress marked a pivotal moment with the disclosure of a clinical trial for Osimertinib mesylate in EGFR-mutated NSCLC patients, opening avenues for further increases in its clinical efficacy.
Read →
Sale of GLP-1 Small Molecule to Eli Lilly, Chugai Pharmaceutical Discloses Latest KRAS Macrocyclic Patent
Hot Spotlight
7 min read
Sale of GLP-1 Small Molecule to Eli Lilly, Chugai Pharmaceutical Discloses Latest KRAS Macrocyclic Patent
16 November 2023
Last year belonged to the realm of Pfizer's COVID-19 small molecule treatments, while this year is dominated by GLP-1 injectable and oral therapies.
Read →
What are CDK9 inhibitors and how do you quickly get the latest development progress?
What are CDK9 inhibitors and how do you quickly get the latest development progress?
16 November 2023
The overexpression of the anti-apoptotic factor Myeloid Cell Leukemia 1 (MCL-1), caused by the activation of CDK9, will lead to the transformation of malignant tumor cells. Therefore, inhibiting CDK9 will downregulate MCL-1, thereby suppressing tumor growth.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.